Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1093/qjmed/94.6.293 http://scihub22266oqcxt.onion/10.1093/qjmed/94.6.293 11391027!ä!11391027 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       QJM 2001 ; 94 (6): 293-300 Nephropedia Template TP {{tp|p=11391027|t=2001. Current management and novel therapeutic strategies for refractory ascites and hepatorenal syndrome |pdf=|usr=}}{{11391027}} gab.com Text Current management and novel therapeutic strategies for refractory ascites and hepatorenal syndrome JO: QJM http://www.kidney.de/pget.php?&tw=1&pmid=11391027 #FOAvip The circulatory disturbances seen in advanced cirrhosis lead to the development of ascites, which can become refractory to diet and medical therapy. These abnormalities may progress and cause a functional renal failure known as the hepatorenal syndrome. Management of refractory ascites and hepatorenal syndrome is a therapeutic challenge, and if appropriate, liver transplantation remains the best treatment. New therapeutic options have recently appeared, including the transjugular intrahepatic portosystemic shunt and selective splanchnic vasoconstrictor agents, which may improve renal function and act as a bridge to transplantation. Twit Text FOAVip Current management and novel therapeutic strategies for refractory ascites and hepatorenal syndrome ????QJM http://www.kidney.de/pget.php?&tw=1&pmid=11391027 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=11391027 #FOAvip English Wikipedia <ref>{{Cite pmid|11391027}}</ref> Current management and novel therapeutic strategies for refractory ascites and hepatorenal syndrome #MMPMID11391027 Suzuki H; Stanley AJ QJM 2001[Jun]; 94 (6): 293-300 PMID11391027show ga The circulatory disturbances seen in advanced cirrhosis lead to the development of ascites, which can become refractory to diet and medical therapy. These abnormalities may progress and cause a functional renal failure known as the hepatorenal syndrome. Management of refractory ascites and hepatorenal syndrome is a therapeutic challenge, and if appropriate, liver transplantation remains the best treatment. New therapeutic options have recently appeared, including the transjugular intrahepatic portosystemic shunt and selective splanchnic vasoconstrictor agents, which may improve renal function and act as a bridge to transplantation. |Ascites/complications/*therapy[MESH] |Atrial Natriuretic Factor/therapeutic use[MESH] |Cardiotonic Agents/therapeutic use[MESH] |Dopamine/therapeutic use[MESH] |Hepatorenal Syndrome/etiology/*therapy[MESH] |Humans[MESH] |Liver Transplantation/methods[MESH] |Paracentesis/methods[MESH] |Peritoneovenous Shunt/methods[MESH] |Portasystemic Shunt, Transjugular Intrahepatic/methods[MESH] |Prostaglandins, Synthetic/therapeutic use[MESH]Current management and novel therapeutic strategies for refractory asc(epmc).pdf DeepDyve Pubget Overpricing